Amarin: Rating Sell With $5 Price Target, 2-Year Timeframe (70% Downside) [Seeking Alpha]
Adamas Pharmaceuticals, Inc. (ADMS)
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.adamaspharma.com/investors
Company Research
Source: Seeking Alpha
Amarin: Rating Sell With $5 Price Target, 2-Year Timeframe (70% Downside) Amarin ( AMRN Amarin stock jumped earlier this year after the REDUCE-IT trial showed PFE MRK NVO A field trip: visit to local pharmacies So it was time to do some field research. I visited 5 large pharmacies in Andover/North Andover/Lawrence area, 30 miles north of Boston (CVS and Walgreens); two of these are open 24-hours. I requested to have a few minutes to talk with the pharmacist in charge, saying that I was doing market research on this drug called Vascepa. The results were surprising to me. A drug which is called the next aspirin or Lipitor was unfamiliar to the majority of pharmacists. These are pharmacists who handle hundreds of prescriptions daily and are well familiar with drugs and their brands. In short, if a drug is selling well and being prescribed, patients will come to get them filled at pharmacies and the pharmacist will know the drug's name well. Four of five pharmacists said that they had not
Show less
Read more
Impact Snapshot
Event Time:
ADMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMS alerts
High impacting Adamas Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics